Is intravenous magnesium sulphate safe to be administered outside the critical care setting?. (26th March 2022)

• Record Type: Journal Article
• Authors: de Havilland, Amanda; Hariharan, Gopakumar; Puvvadi, Ramaa
• Is Part Of: Journal of paediatrics and child health. Volume 58:Number 5(2022)
• Page Start: 924
• Page End: 928
• Publication Date: 2022-03-26
• Subjects: asthma -- magnesium -- paediatrics; sulphate; Children -- Health and hygiene -- Periodicals; Pediatrics -- Periodicals; 618.92
• DOI: 10.1111/jpc.15951
• Languages: English
• ISSNs: 1034-4810

Abstract

Abstract : Aim: To review current evidence regarding the safety of intravenous bolus magnesium sulphate for the treatment of children with acute severe asthma in the non‐critical care setting. Methods: MEDLINE via Ovid, Embase and the Cochrane Library were searched for relevant articles. Results: Four hundred and eighteen articles were identified during the initial search after removal of duplicates. Eighty full‐text articles were selected for review and 16 included as relevant to the clinical question. Conclusions: Current evidence suggests that bolus intravenous magnesium sulphate is safe to be administered in non‐critical care settings provided that line of sight nursing and cardiorespiratory monitoring are available.